(Q51360464)

4 April 2018

title

NPY modulates PYY function in the regulation of energy balance and glucose homeostasis. (English)

1 reference

4 April 2018

E Yulyaningsih

4

0 references

Amanda Sainsbury

object named as

A Sainsbury

11

0 references

author name string

L Zhang

1

1 reference

4 April 2018

A D Nguyen

2

1 reference

4 April 2018

I-C J Lee

3

1 reference

4 April 2018

S J Riepler

5

1 reference

4 April 2018

B Stehrer

6

1 reference

4 April 2018

R F Enriquez

7

1 reference

4 April 2018

S Lin

8

1 reference

4 April 2018

Y-C Shi

9

1 reference

4 April 2018

P A Baldock

10

1 reference

4 April 2018

H Herzog

12

1 reference

4 April 2018

publication date

21 March 2012

1 reference

4 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

4 April 2018

volume

14

1 reference

4 April 2018

issue

8

1 reference

4 April 2018

page(s)

727-736

1 reference

4 April 2018

Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Distribution of pancreatic polypeptide and peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Peptide YY kinetics and effects on blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Salivary PYY: a putative bypass to satiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Y-receptor subtypes--how many more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Attenuation of diabetic hyperphagia in neuropeptide Y--deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Behavioural profile of a new mouse model for NPY deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

The theoretical bases of indirect calorimetry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Behavioral characterization of neuropeptide Y knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Role of the arcuate nucleus of the hypothalamus in regulation of body weight during energy deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Peptide YY does not inhibit glucose-stimulated insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Effects of intravenous neuropeptide Y on insulin secretion and insulin sensitivity in skeletal muscle in normal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Evaluating the glucose tolerance test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Effects of PYY1–36 and PYY3–36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2012.01592.X

10.1111/J.1463-1326.2012.01592.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

22369253

1 reference

4 April 2018